American Journal of Nanomaterials
ISSN (Print): 2372-3114 ISSN (Online): 2372-3122 Website: http://www.sciepub.com/journal/ajn Editor-in-chief: Apply for this position
Open Access
Journal Browser
Go
American Journal of Nanomaterials. 2016, 4(1), 12-19
DOI: 10.12691/ajn-4-1-3
Open AccessArticle

Time-dependent Toxic Effect and Distribution of Silver Nanoparticles Compared to Silver Nitrate after Intratracheal Instillation in Rats

Alaa Fehaid1, 2, Mohamed F. Hamed3, Mamdouh M. Abouelmagd2 and Akiyoshi Taniguchi1, 4,

1Cellular Functional Nanobiomaterials Group, Research Center for Functional Materials, National Institute for Materials Science (NIMS), Tsukuba, Ibaraki, Japan

2Department of Forensic Medicine and Toxicology, Faculty of Veterinary Medicine, Mansoura University, Mansoura, Egypt

3Department of Pathology, Faculty of Veterinary Medicine, Mansoura University, Mansoura, Egypt

4Graduate School of Advanced Science and Engineering, Waseda University, Tokyo, Japan

Pub. Date: June 12, 2016

Cite this paper:
Alaa Fehaid, Mohamed F. Hamed, Mamdouh M. Abouelmagd and Akiyoshi Taniguchi. Time-dependent Toxic Effect and Distribution of Silver Nanoparticles Compared to Silver Nitrate after Intratracheal Instillation in Rats. American Journal of Nanomaterials. 2016; 4(1):12-19. doi: 10.12691/ajn-4-1-3

Abstract

Silver nanoparticles (AgNPs) are widely used because of their anti-bacterial and anti-inflammatory properties; however, the adverse health effects of these nanoparticles, especially to the lungs, have been less studied. We thus investigated the inflammatory response of polyvinylpyrrolidone (PVP)-coated AgNPs and silver nitrate (AgNO3) after 24 h, 14 days and 28 days of single intratracheal instillation in rats. The bronchoalveolar lavage fluid (BALF) samples were collected and analyzed; a significant influx of neutrophils into the lung was found in both treated groups after 24 h with a presence of AgNPs in the alveolar macrophages after 24 h, 14 days and 28 days of instillation. Pro-inflammatory cytokines and enzymatic activities showed a significant increase after 24 h in both treated groups with a higher significance in the AgNO3-treated group than the AgNPs-treated group. After 28 days, these increases were completely recovered in the AgNO3-treated group but were still present in the AgNPs-treated group. The gross examination of lung tissues revealed a clear focal inflammation in the AgNPs-treated group after 28 days. More than 29% and 9% of the initial dose of AgNPs were recovered in lung tissues after 1 day and 28 days, respectively. Comparatively, the AgNO3-treated group recovered only 16.5% and 1%, suggesting that the silver ions are easily absorbed into the circulation and distributed to different tissues more than the nanoparticles. Our results indicated that the PVP-AgNPs caused a subchronic pulmonary inflammation compared to the acute one induced by the ionic form, which can be recovered easily.

Keywords:
silver nanoparticles pulmonary inflammation silver distribution toxicity

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

Figures

Figure of 7

References:

[1]  Wiegand, C., Heinze, T. and Hipler, U.C. “Comparative in Vitro Study on Cytotoxicity, Antimicrobial Activity, and Binding Capacity for Pathophysiological Factors in Chronic Wounds of Alginate and Silver-Containing Alginate,” Wound Repair and Regeneration, 17. 511-521. 2009.
 
[2]  Fichtner, J., Güresir, E., Seifert, V. and Raabe, A. “Efficacy of silver-bearing external ventricular drainage catheters: A retrospective analysis,” J. Neurosurg., 112. 840-846. 2010.
 
[3]  Ng, C.T., Li, J.J., Perumalsamy, R., Watt, F., Yung, L.Y.L. and Bay, B.H. “Localizing cellular uptake of nanomaterials in vitro by transmission electron microscopy,” Microsc Sci Technol Appl Educ 1. 316-320. 2010.
 
[4]  Ratyakshi and Chauhan, R.P. “Colloidal synthesis of silver nanoparticles,” Asian J Chem ., 21(10). S113-S116. 2009.
 
[5]  Edwards-Jones, V. “The benefits of silver in hygiene, personal care and healthcare,” Lett. Appl. Microbiol., 49. 147-152. 2009
 
[6]  Walser, T., Demou, E., Lang, D.J. and Hellweg, S. “Prospective environmental life cycle assessment of nanosilver T-shirts,” Environ Sci Technol, 45(10). 4570-4578. 2011.
 
[7]  Ahamed, M., Karns, M., Goodson, M., Rowe, J., Hussain, S.M., Schlager, J.J. and Hong, Y., “DNA damage response to different surface chemistry of silver nanoparticles in mammalian cells,” Toxicol. Appl. Pharmacol., 233. 404-410. 2008.
 
[8]  Quadros, M.E. and Marr, L. C. “Silver Nanoparticles and Total Aerosols Emitted by Nanotechnology-Related Consumer Spray Products,” Environ. Sci. Technol., 45. 10713-10719. 2011.
 
[9]  Schleh, C. and Hohlfeld, J. M. “Interaction of nanoparticles with the pulmonary surfactant system,” Inhalation Toxicol., 21 (1). 97-103. 2009.
 
[10]  Chairuangkitti, P., Lawanprasert, S., Roytrakul, S., Aueviriyavit, S., Phummiratch, D., Kulthong, K., Chanvorachote, P. and Maniratanachote, R. “Silver nanoparticles induce toxicity in A549 cells via ROS-dependent and ROS independent pathways,” Toxicology in Vitro, 27(1). 330-338. 2013.
 
[11]  Gliga, A.R., Skoglund, S., Wallinder, I.O., Fadeel, B. and Karlsson, H.L. “Size-dependent cytotoxicity of silver nanoparticles in human lung cells: the role of cellular uptake, agglomeration and Ag release,” Part Fibre Toxicol., 11(11). 1-17. 2014.
 
[12]  Foldbjerg, R., Dang, D. A. and Autrup, H. “Cytotoxicity and genotoxicity of silver nanoparticles in the human lung cancer cell line, A549,” Arch Toxicol 85. 743-750. 2011.
 
[13]  Handerson R. F. “Use of bronchoalveolar lavage to detect respiratory tract toxicity of inhaled material,” Experimental and Toxicological Pathology, 57(1). 155-159. 2005.
 
[14]  Haberl, N., Hirn, S., Wenk, A., Diendorf, J., Epple, M., Johnston, B., Krombach, F., Kreyling, W.G. and Schleh, C. “Cytotoxic and proinflammatory effects of PVP-coated silver nanoparticles after intratracheal instillation in rats,” Beilstein J of Nanotechnology, 4. 933-940. 2013.
 
[15]  Kaewamatawong, T., Banlunara, W., Maneewattanapinyo, P., Thammacharoen, C. and Ekgasit, S. “Acute Pulmonary Toxicity Caused by Single Intratracheal Instillation of Various Doses of Colloidal Silve Nanoparticles in Mice: Pathological Changes, Particle Bioaccumulation and Metallothionien Protein Expression,” Thai J Vet Med., 43(3). 383-390. 2013.
 
[16]  Arai, Y., Miyayama, T. and Hirano, S. “Difference in the toxicity mechanism between ion and nanoparticle forms of silver in the mouse lung and in macrophages,” Toxicology 328. 84-92. 2015.
 
[17]  Kittler, S., Greulich, C., Diendorf, J., Köller, M. and Epple, M. “Toxicity of Silver Nanoparticles Increases during Storage Because of Slow Dissolution under Release of Silver Ions,” Chem. Mater., 22. 4548-4554. 2010.
 
[18]  Sung, J.H., Ji, J.H., Park, J.D., Yoon, J.U., Kim, D.S., Jeon, K.S., Song, M.Y., Jeong, J., Han, B.S., Han, J.H., Chung, Y.H., Chang, H.K., Lee, J.H., Cho, M.H., Kelman, B.J. and Yu, I.J. “subchronic inhalation toxicity of silver nanoparticles,” Toxicological sciences, 108(2). 452-461. 2009
 
[19]  Thakur, M., Gupta, H., Singh, D., Mohanty, l.R., Maheswari, U., Vanage, G. and Joshi, D.S. “Histopathological and ultra structural effects of nanoparticles on rat testis following 90 days (Chronic study) of repeated oral administration,” Journal of Nanobiotechnology, 12. 42. 2014.